AutoNation's stock rises toward 6-week high after profit beats expectations, while revenue fell short
Shares of AutoNation Inc. (AN) rallied 1.9% toward a six-week high in premarket trading Thursday, after the new and used car seller missed first-quarter revenue expectations but beat on profit, amid strength in its used-vehicles business. Net income fell to $288.7 million from $362.1 million, while earnings per share increased to $6.02 from $5.78, as the weighted average number of shares outstanding dropped to 47.6 million from 62.6 million. That beat the FactSet EPS consensus of $5.74. Revenue fell 5.2% to $6.40 billion, below the FactSet consensus of $6.63 billion. New vehicle revenue rose 4% to $2.9 billion, while new vehicle gross profit per vehicle dropped 14.8% to $5,210. Used vehicle revenue fell 21% to $2.0 billion, but used vehicle gross profit per vehicle climbed 35.2% to $1,566. "Consumer demand for personal vehicle ownership remains strong, and AutoNation is meeting this demand through its sourcing capabilities, selection of vehicles, footprint, digital tools, core efficiencies, and business expansions," said Chief Executive Officer Mike Manley. The stock has run up 27.1% year to date through Wednesday, while the S&P 500 has gained 8.2%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-20-23 0848ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth